...
机译:Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis.
Department of Pharmacy, University of Washington, Seattle, USA. lgarrisn@u.washington.edu;
Drug Approval; Drug Industry; Evidence-Based Medicine; Humans; Models; Theoretical; 药物批准; 制药工业; 证据医学; 模型; 理论; 结果评价(卫生保健); 质量校正寿命;